Rasha Youssef
Family Medicine · Boynton Beach, FLNPI 1154376648
Payments from drug & device makers
Across 950 payments — averaging $7796.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$2.4M
- Janssen Research & Development, LLC$2M
- Boehringer Ingelheim International GmbH$1.2M
- Boehringer Ingelheim$541K
- F. Hoffmann-la Roche AG$315K
- Novartis$217K
- plus $836K from 22 others
Across 4 payments — averaging $8473.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$34K
What the payments were for
- Travel & lodging$2816%
- Food & beverage$4,24594%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 32 | $2,368,436 |
| Janssen Research & Development, LLC | 111 | $1,950,772 |
| Boehringer Ingelheim International GmbH | 333 | $1,178,077 |
| Boehringer Ingelheim | 76 | $541,365 |
| F. Hoffmann-la Roche AG | 96 | $315,260 |
| Novartis | 9 | $216,917 |
| Genentech, Inc. | 61 | $196,527 |
| Amgen | 7 | $185,225 |
| Modernatx, Inc. | 43 | $91,561 |
| Chiesi USA, Inc. | 81 | $79,936 |
| Ionis Pharmaceuticals, Inc. | 17 | $73,545 |
| Acella Pharmaceuticals, LLC | 30 | $69,833 |
| AstraZeneca | 8 | $36,565 |
| Alnylam Pharmaceuticals Inc. | 6 | $34,184 |
| Braintree Laboratories, Inc. | 12 | $22,084 |
| Merck | 2 | $19,953 |
| Avion Pharmaceuticals | 3 | $12,300 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 3 | $11,685 |
| Bayer | 6 | $589 |
| Johnson & Johnson | 4 | $448 |
| Novo Nordisk | 3 | $306 |
| Silk Road Medical, Inc. | 1 | $187 |
| Shockwave Medical, Inc | 1 | $140 |
| Atricure, Inc. | 1 | $136 |
| Abbott | 1 | $135 |
| Lilly USA, LLC | 1 | $124 |
| Boston Scientific | 1 | $122 |
| Pfizer | 1 | $116 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$738
- FARXIGA$494
- Kerendia$481
- XARELTO$448
- ENROUTE Transcarotid Neuroprotection System$187
- ENROUTE Transcarotid Stent$187
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$140
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$136
- Confirm Rx$135
- ENTRESTO$125
- ZEPBOUND$124
- JARDIANCE$123
- Watchman$122
- AMVUTTRA$122
- BRILINTA$116
- VYNDAQEL$116
How this compares
$7,406,529 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Boynton Beach
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Dario AltamiranoHialeah$15.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.